Buy Guide
Twitter
  • Home
  • Guide
  • SPAGG
  • Research
  • Education
  • Jobs
  • Contact
  • Community
  • Add listing
  • Home
  • Guide
  • SPAGG
  • Research
  • Education
  • Jobs
  • Contact
  • Community
  • Add listing

Keppra

Levetiracetam (Keppra) Study

  • Share
  • Project Page
  • prev
  • next
  • Share
  • Bookmark
  • Report
  • prev
  • next
Background and Objectives

An exploration into the use of continuous subcutaneous Levetiracetam within palliative care.
This piece of work aimed to review the current evidence and guidance around the use of Levetiracetam for seizure control within palliative care settings. Literature reviews were performed as well as seeking local expert opinion. This is an area of active growing research with the aim to create consistent evidence based guidance.

Method

Please download our PDF for more information.

Details
  • Organisation: WMCARES
Files
  • LevetiracetamposterBelfast.pdf View
Project Type
  • Past Project

You May Also Be Interested In

Withdrawal of Non Invasive Ventilation in patients with respiratory failure in the hospital setting

(Work undertaken prior to COVID-19 pandemic)
  • By WM CARES

An evaluation of the use of subcutaneous furosemide in end stage heart failure in the West Midlands, using an online survey tool

Poster authors: Abi Reynolds, Nik Sanyal, Alice Gray
  • By WMCARES

Exploring confidence of palliative care professionals in the identification and assessment of mental health problems and risk

Patients with life-limiting illness seen by professionals in palliative care commonly experience mental…
  • By WMCAREs
  • Palliative Care Guidance
  • Specialist Guidelines
  • Research Projects
  • Education & Events

Copyright 2025© All rights Reserved. Design by Citrus Frog

Cart

  • Facebook
  • X
  • WhatsApp
  • Telegram
  • Pinterest
  • LinkedIn
  • Tumblr
  • Reddit
  • VKontakte
  • Mail
  • Copy link
  • Share via...
  • Facebook
  • X
  • WhatsApp
  • Telegram
  • Pinterest
  • LinkedIn
  • Tumblr
  • Reddit
  • VKontakte
  • Mail
  • Copy link
  • Share via...